Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Smith Nephew ADR Representing 2 Ord Shs C.SNN


Primary Symbol: SNN

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.


NYSE:SNN - Post by User

Comment by thetis88on Dec 06, 2018 11:36am
177 Views
Post# 29075979

RE:RE:RE:Another SNN article quote, “UNDERVALUED”

RE:RE:RE:Another SNN article quote, “UNDERVALUED”Thats a good point Bluesguy. I have no intent to say--- I told you so ---when i come back.
I am trying to provide facts to a crowd that  is married to this  stock, and   base their comments  not on the  financials, as I suspect none of them even  read the financials. I know that as soon as I saw a post saying something dead wrong ( in my opinion) that I would quickly respond, and wanted something that would stop me responding to each negative post. So I chose not to write until the stock was below $2.50.
,
The problem is when do you know Sunniva is out of cash, and I am right ,or has lots  of cash and I am wrong? I guess you have to wait till the first quarter is reported, and that is not until May 30, 2019.
I expect an attempt at another PP in February 2019, and that will require a press release in late January. By looking at the prospectus, we will know at that date, they are out of cash.
If there is no PP, then either the investment dealers could not sell Sunniva stock at any price, or they have plenty of cash on hand. Its simply a fact, whether they have cash on hand or not, and it will all come out in the wash.
Got Money- I have taken extended good sales into account in my negative cash flow calculation. I am just including the expenses related  to those sales as well. .Also,  don't forget the 3 million rent starting January,  as additional  cash out the door, thats not happening now.
A lot of the cash from the last pp went to pay off their bills. At march 31 2018 the financials showed over 10 million in accounts payable.  They used the PP to simply pay their bills.
Each quarter they lose over 5 million. . Together with all the start up costs, a new warehouse, a new facility in Canada,  new rent, a new distribution payroll, lots of new staff, I expect a net cash loss in the first quarter, that will far exceed their cash on hand.
See you again  at $ 2.49 a share .
 I have no idea when that will be ,but at some point the stock price will reflect the negative cash flows and fall to zero, so I suspect to be on this Board again before the end of the month.
<< Previous
Bullboard Posts
Next >>